A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

Details for Australian Patent Application No. 2002359857 (hide)

International Classifications

Event Publications

3 April 2003 Complete Application Filed

Priority application(s): 60/366,351 21.03.02 US; 60/344,120 28.12.01 US

4 September 2003 Application Open to Public Inspection

Published as AU-B-2002359857

11 December 2008 Application Accepted

Published as AU-B-2002359857

8 January 2009 Corrigenda

Applications Accepted - Name Index Under the Name Teva Pharmaceutical Industries Ltd., Application No. 2002359857, under INID (72) correct the coinventor to Leibovici, Minutza

9 April 2009 Standard Patent Sealed

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.